Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of EIKN will rise by +0.02% over the next 2 Weeks and hit $11.16 by Wednesday, June 3, 2026. In that time frame, EIKN's share price is expected to range between $9.77 and $12.48.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 1, 2026 | 10.45 | 11.80 | 13.22 |
EIKN shares fell -0.06% in Friday, May 22, 2026's trading session, dropping from a previous close of $11.16 to move at $11.15. The stock demonstrated notable intraday movement (see EIKN's key stats for a full breakdown), fluctuating between $10.82 and $11.50, a +6.24% trading range. While recent weeks have seen some volatility, EIKN has managed to secure a +11.98% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 185.2K shares changing hands, 51.37K fewer than the previous session. This amounted to $2.07M in total market activity.
Will EIKN Continue Its Upward Trend?
According to analyst ratings and projections for EIKN, Eikon Therapeutics, Inc. Common Stock shares are anticipated to increase by +15.61%, potentially reaching $13.22 per share by June 1, 2026. Short-term technical indicators currently suggest a neutral sentiment for EIKN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the EIKN stock forecast, now is a good time to buy EIKN stock because its current trading price is -5.44% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on EIKN covering social and institutional perspectives.
EIKN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into EIKN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.46% to 51.50%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.23%, suggests a neutral medium-term outlook. Insights into EIKN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Eikon Therapeutics Common Stock Short-Term Forecasts
EIKN Forecast For Next 5 Days
Our algorithm anticipates Eikon Therapeutics Common Stock (EIKN) stock could hit $8.44 by May 29, 2026. This represents a -24.37% fall from today's price, following a - change over the past five days.
EIKN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Eikon Therapeutics, Inc. Common Stock (EIKN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $9.25, which would mean a -17.07% decrease from the current price of $11.15. Projections for this period range from a high of $12.74 to a low of $6.21.
EIKN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Eikon Therapeutics Common Stock's price over the next three months point to a rise. EIKN stock is expected to peak at $37.34 on Jun 03, 2026 after potentially dipping to $15.52 on May 25, 2026. On average, EIKN is likely to trade around $24.33 in the coming 90 days.
Eikon Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Eikon Therapeutics Common Stock (EIKN) is expected to trade between $9.34 and $37.34 throughout 2026. This would result in an average price of $18.61, potentially offering investors a +66.85% return from current levels.
Eikon Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Eikon Therapeutics, Inc. Common Stock (EIKN) is positioned to show a strong performance in May 2026. The price is predicted to move between $15.52 and $23.26, settling at an average of $18.78. This could translate to a +68.38% gain.
June 2026
Based on current market signals, Eikon Therapeutics, Inc. Common Stock is projected to trend june 2026. We forecast a trading range from $19.49 to $37.34, with a likely average price of $28.16. Investors could expect a potential return of +152.47%.
July 2026
Our predictive algorithms indicate Eikon Therapeutics, Inc. Common Stock stock may see a shift in July 2026. The expected range spans $20.05–$26.38, with an average target of $23.89. This represents a positive outlook and a possible gain of +114.19%.
August 2026
Analyzing established trends, Eikon Therapeutics, Inc. Common Stock looks set to move in August 2026. Projections place the stock between $18.48 and $23.92, averaging around $20.86. This suggests a +87.02% gain from current levels.
September 2026
Market indicators suggest Eikon Therapeutics, Inc. Common Stock could experience notable changes during September 2026. Prices could fluctuate within $14.82 to $20.50, with a midpoint forecast of $17.50. The stock might deliver a +56.90% gain.
October 2026
Forecasting for October 2026, models estimate that Eikon Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $9.34 and $19.21, averaging $15.45. This signals a positive trajectory with potential returns around +38.52%.
November 2026
According to our latest forecast models, Eikon Therapeutics, Inc. Common Stock (EIKN) is positioned to show a strong performance in November 2026. The price is predicted to move between $9.35 and $18.88, settling at an average of $13.14. This could translate to a +17.81% gain.
December 2026
Based on current market signals, Eikon Therapeutics, Inc. Common Stock is projected to trend december 2026. We forecast a trading range from $9.41 to $12.56, with a likely average price of $11.17. Investors could expect a potential return of +0.15%.
January 2027
Our predictive algorithms indicate Eikon Therapeutics, Inc. Common Stock stock may see a shift in January 2027. The expected range spans $6.60–$10.63, with an average target of $8.61. This represents a cautious outlook and a possible loss of -22.81%.
February 2027
Analyzing established trends, Eikon Therapeutics, Inc. Common Stock looks set to move in February 2027. Projections place the stock between $6.00 and $8.01, averaging around $6.86. This suggests a -38.50% loss from current levels.
March 2027
Market indicators suggest Eikon Therapeutics, Inc. Common Stock could experience notable changes during March 2027. Prices could fluctuate within $2.84 to $7.28, with a midpoint forecast of $5.56. The stock might deliver a -50.15% loss.
April 2027
Forecasting for April 2027, models estimate that Eikon Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $2.67 and $6.15, averaging $3.94. This signals a cautious trajectory with potential returns around -64.68%.
May 2027
According to our latest forecast models, Eikon Therapeutics, Inc. Common Stock (EIKN) is positioned to show a strong performance in May 2027. The price is predicted to move between $2.79 and $4.11, settling at an average of $3.58. This could translate to a -67.90% loss.
EIKN's history of dividends and stock splits also plays a role in long-term investor confidence.